(Total Views: 248)
Posted On: 04/26/2019 3:10:42 PM
Post# of 15445
$PTLA News Article - European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals' Ondexxya(TM) (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors https://marketwirenews.com/news-releases/euro...66946.html
(0)
(0)
My Twitter: WhyteStocks
